Governor Cuomo Announces 12 New York Companies to Start Producing COVID-19 Related Equipment and Supplies to Support In-State Needs

SourceThe Official Website of New York State
Date Published07/30/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Empire Bio Diagnostics Corp
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2020
Domestically, the work will be done:Both
Capital investment ($):2
City reshored to:Long Island, Syracuse
State(s) reshored to:NY
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredViral Transport Medium Kits, plastic inj. molding
What non-domestic negative factors made offshoring less attractive?Loss of control, Travel cost/time
What domestic positive factors made reshoring more attractive?Customer responsiveness improvement, Government Incentives, Higher productivity, Infrastructure, Image/brand, Impact on domestic economy, Lead time/Time to market, Proximity to customers/market, Under-utilized capacity, Covid-19
Government Incentive dollar amount:$500,000
Find Reshoring Articles